A detailed history of Black Rock Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Black Rock Inc. holds 19,850,864 shares of NEO stock, worth $272 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,850,864
Previous 19,980,993 0.65%
Holding current value
$272 Million
Previous $323 Million 3.48%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$14.06 - $16.79 $1.83 Million - $2.18 Million
-130,129 Reduced 0.65%
19,850,864 $312 Million
Q4 2023

Feb 13, 2024

SELL
$11.67 - $20.73 $1.42 Million - $2.53 Million
-121,915 Reduced 0.61%
19,980,993 $323 Million
Q3 2023

Nov 13, 2023

SELL
$12.15 - $17.85 $8.18 Million - $12 Million
-673,304 Reduced 3.24%
20,102,908 $247 Million
Q2 2023

Aug 11, 2023

SELL
$14.1 - $19.83 $7.5 Million - $10.6 Million
-532,168 Reduced 2.5%
20,776,212 $334 Million
Q1 2023

May 12, 2023

SELL
$9.09 - $19.45 $5.68 Million - $12.2 Million
-625,097 Reduced 2.85%
21,308,380 $371 Million
Q4 2022

Feb 13, 2023

BUY
$6.45 - $12.07 $5.32 Million - $9.95 Million
824,295 Added 3.9%
21,933,477 $203 Million
Q3 2022

Nov 14, 2022

BUY
$7.86 - $12.91 $621,372 - $1.02 Million
79,055 Added 0.38%
21,109,182 $182 Million
Q2 2022

Aug 12, 2022

BUY
$7.06 - $13.97 $10.2 Million - $20.1 Million
1,440,078 Added 7.35%
21,030,127 $171 Million
Q1 2022

May 12, 2022

BUY
$12.15 - $35.28 $3.18 Million - $9.24 Million
261,795 Added 1.35%
19,590,049 $238 Million
Q4 2021

Feb 10, 2022

BUY
$30.49 - $48.49 $17.3 Million - $27.6 Million
569,039 Added 3.03%
19,328,254 $659 Million
Q3 2021

Nov 09, 2021

BUY
$41.66 - $52.52 $1.53 Million - $1.93 Million
36,710 Added 0.2%
18,759,215 $905 Million
Q2 2021

Aug 11, 2021

BUY
$36.62 - $51.69 $686 Million - $968 Million
18,722,505 New
18,722,505 $846 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.72B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.